SMTL ID : 5fbn.1 (1 other biounit)

BTK kinase domain with inhibitor 1

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.80 Å

Oligo State

monomer

Ligands

1 x 5WF: 4-[8-azanyl-3-[(3~{R})-1-(3-methyloxetan-3-yl)carbonylpiperidin-3-yl]imidazo[1,5-a]pyrazin-1-yl]-~{N}-[4-(trifluoromethyl)pyridin-2-yl]benzamide(Non-covalent)

5WF.1: 24 residues within 4Å: Chain A: L.20, G.21, T.22, V.28, A.40, K.42, F.54, A.58, M.61, M.62, L.72, I.84, T.86, E.87, Y.88, M.89, G.92, C.93, N.96, L.140, S.150, D.151, F.152, L.154 14 PLIP interactions: 14 interactions with chain A Hydrophobic interactions: A:V.28, A:K.42, A:L.72, A:L.72, A:T.86, A:L.140, A:L.154, A:L.154 Hydrogen bonds: A:E.87, A:M.89, A:C.93, A:S.150, A:D.151, A:F.152

1 x 5WE: 4-[8-azanyl-3-[(2~{S})-1-[4-(dimethylamino)butanoyl]pyrrolidin-2-yl]imidazo[1,5-a]pyrazin-1-yl]-~{N}-(1,3-thiazol-2-yl)benzamide(Non-covalent)

5WE.2: 7 residues within 4Å: Chain A: I.9, W.33, Y.37, V.39, S.65, Q.71, Y.73 11 PLIP interactions: 11 interactions with chain A Hydrophobic interactions: A:Y.37, A:Y.37, A:V.39, A:Q.71, A:Y.73, A:Y.73, A:Y.73 Hydrogen bonds: A:S.65, A:Y.73 pi-Stacking: A:W.33, A:Y.73

1 x CL: CHLORIDE ION(Non-functional Binders)

CL.3: 6 residues within 4Å: Chain A: E.19, L.20, G.21, V.27, V.28, K.29 Ligand excluded by PLIP

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Liu, J. et al., Discovery of 8-Amino-imidazo[1,5-a]pyrazines as Reversible BTK Inhibitors for the Treatment of Rheumatoid Arthritis. Acs Med.Chem.Lett. (2016)

Release Date

2016-02-03

Peptides

Tyrosine-protein kinase BTK: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
C

Tyrosine-protein kinase BTK

Related Entries With Identical Sequence